middle.news
EVE Health Launches Dyspro™ and Libbo™ with $1.1M Boost for Commercial Rollout
11:42am on Friday 31st of October, 2025 AEDT
•
Healthcare
Read Story
EVE Health Launches Dyspro™ and Libbo™ with $1.1M Boost for Commercial Rollout
11:42am on Friday 31st of October, 2025 AEDT
Key Points
First patient prescriptions of Dyspro™ for dysmenorrhoea and endometriosis
Libbo™ receives first commercial purchase order ahead of December launch
$1.1 million placement completed to fund commercial rollout and education
Launch of Reclaim My Cycle online platform for women’s health education
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
EVE
OPEN ARTICLE